Literature DB >> 28648963

The association between diabetes, level of glycaemic control and eye infection: Cohort database study.

Abdus Samad Ansari1, Simon de Lusignan2, William Hinton2, Neil Munro2, Andrew McGovern2.   

Abstract

AIM: To examine whether diabetes and the degree of glycaemic control is associated with an increased risk of acute eye infection, and prescribing of ocular antimicrobial agents. DESIGN AND
SETTING: A retrospective cohort study was carried out using the Royal College of General Practitioners Research and Surveillance Centre database (RCGP RSC), a large primary care database in the United Kingdom. We compared ocular infection rates in people aged ≥15 years without diabetes to those with diabetes, both type 1 and type 2. We developed logistic regression models to assess the excess risk in diabetes of: conjunctivitis, blepharitis, stye/chalzion, periorbital cellulitis, keratitis/keratoconjunctivitis, lacrimal gland infection, endopthalmitis, and ocular antimicrobial prescriptions over a six-year period (2010-2015). We also analysed the impact of glycaemic control on infection rates in those with diabetes. All models were adjusted for potential confounders.
RESULTS: We analysed infection risk in 889,856 people without diabetes and 48,584 people with diabetes (3273 type 1, and 45,311 type 2). After adjustment for confounders both type 1 and type 2 were associated with increased incidence of conjunctivitis (OR 1.61; 95% CI 1.38-1.88; p<0.0001 and OR 1.11; 95% CI 1.06-1.16; p<0.0001 respectively). No association was found with blepharitis, stye/chalzion, periorbital cellulitis, keratitis/keratoconjunctivitis, lacrimal gland infection, and endopthalmitis in the whole population. In subgroup analyses blepharitis was more common in those with type 1 diabetes under 50 years old and endopthalmitis in those under 50 with type 2 diabetes. Glycaemic control was not found to be associated with any infection. Diabetes was also associated with an increased incidence of antimicrobial prescriptions (Type 1 OR 1.69; 95% CI 1.51-1.88; p<0.0001 and type 2 OR 1.17; 95% CI 1.13-1.20; p<0.0001).
CONCLUSIONS: Conjunctivitis is recorded more frequently in people with diabetes. However, no substantial increase in recording of other ocular infections was noted. Infection risk was not found to be associated with the degree of glycaemic control.
Copyright © 2017 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blepharitis; Complications; Conjunctivitis; Endopthalmitis; Eye infections; Glycaemic control; Periorbital cellulitis; Retinopathy

Mesh:

Substances:

Year:  2017        PMID: 28648963     DOI: 10.1016/j.pcd.2017.05.009

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  6 in total

Review 1.  Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

2.  Ocular Surface Diseases in Patients With Diabetes.

Authors:  Kunj Naik; Renu Magdum; Amod Ahuja; Sucheta Kaul; Johnson S; Ashish Mishra; Mayur Patil; Dr Nilay Dhore; Aparna Alapati
Journal:  Cureus       Date:  2022-03-22

3.  Adipocytokine expression, platelet-to-lymphocyte ratio and TGF-β1/Smad signaling activity in diabetic patients complicated with pulmonary infection.

Authors:  Mei Zha; Xiao-Bing Ren; Jing Chen; Ying Fang; Ping Yu; Yan-Yin Liu; Gang Wang; Jun Luo; Jing Yang; Ting-Wei Gou
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 4.  Eye care providers' emerging roles in early detection of diabetes and management of diabetic changes to the ocular surface: a review.

Authors:  Kathryn Richdale; Cecilia Chao; Marc Hamilton
Journal:  BMJ Open Diabetes Res Care       Date:  2020-04

5.  Recommendations for management of diabetes and its complications during Hajj (Muslim pilgrimage).

Authors:  Mahmoud Ibrahim; Sulaf I Abdelaziz; Megahed Abu Almagd; Monira Alarouj; Firas A Annabi; David G Armstrong; Ebtesam Ba-Essa; Abdullah Ben Nakhi; Nadia Boudjenah; Amy Hess Fischl; Al Ghomari Hassan; Shabeen Naz Masood; Aly A Misha'l; A Samad Shera; Jaakko Tuomilehto; Guillermo E Umpierrez
Journal:  BMJ Open Diabetes Res Care       Date:  2018-08-17

6.  Bloodletting at EX-HN6 as an adjunctive therapy to eye drops for stye: A meta-analysis.

Authors:  Hong-Wei Qiao; Na-Wen Liu; Jin Wang; Shan Huang; Lei Yu; Zhong Chen
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.